Sharing our new Health Affairs Forefront article that details why bad process measures can be dangerous for patients boarding in the Emergency Department. www.healthaffairs.org/content/fore...
#HealthPolicySky #EmergencyMedicine #Boarding #QualityMetrics 🧵 1/3
The #alcohol industry is right up there with Big #Tobacco! #healthpolicysky
#publuchealthsky
#AcademiaSky #HealthPolicySky are there any low-stakes outlets where people share “I’m researching this thing and here’s what I’ve learned so far” short of like… starting a blog?
Background image of Oregon's capital with a blue overlay. White text at the top says "Cutting prescription drug cots: Lessons from other states. Three photos of people in circle frames are below. The first is a picture of a man in a tie, underneath white text reads Vincent DeMarco President Maryland Health Care for All. The second is a picture of a man with glasses and a beard, underneath white text reads Charlie Fisher, Heath Care Campaign Advocate OSPIRG, and the final one hows a picture of a woman with dark hair, underneath text reads:Priya Telang, Communications Manager Colorado Consumer Health Initiative. Below that the event details are Public interest policy forum, Dec. 4 6:00 pm. Location Kiln 1120 SE Madison St. Portland, OR 97214
Join #OCAP, #OSPIRG, and @healthcareforallor.bsky.social for a great event tomorrow in #Portland! Learn why prescription drugs are so expensive and how we can make a change. Attendance is free.
RSVP here: pirg.org/oregon/event...
#AffordablePrescriptions #DrugPrices #HealthPolicySky #Oregon
A green background with a white border. White text at the top says: Leadership Changes. Below text says: Vice Chair Dr. Amy Burns resigned effective November 16. Dr. Dan Hartung was elected the new Vice Chair of the Oregon PDAB and began serving immediately. A white icon of a turning gear with icons of people inside
A green background with a white border. White text at the top says: Annual Report. Below text says: Board members reviewed and discussed the Draft 2025 Annual Report. Board members asked why some data columns did not add up. Staff and analysts explained these variances are due to the requirement that insurance carriers submit the top drugs for each segment (and they don’t always overlap) The board agreed to add clarifying statements to the report to acknowledge that. A white icon of a report on a clipboard with a calculator
A green background with a white border. White text at the top says: Policy Recommendations Below text says: The board voted to recommend these policies to Oregon lawmakers: ✓ PBM transparency reforms ✓ “Any-willing-provider” pharmacy access ✓ Permanent CAT tax exemption for pharmacies ✓ Single statewide PBM for Medicaid ✓ Uniform Medicaid Preferred Drug List ✓ Study on Medicaid pharmacy carve-out ✓ New affordability tools (cost-plus, POS rebates) ✓ Expanded PDAB scope ✓ Updated confidentiality rules for trade-secret info
A green background with a white border. White text at the top says: Looking Ahead. White text below says: Next PDAB Meeting: December 17, 2025 at 8 am, Board members will come prepared to nominate specific drugs that they believe present affordability challenges. A white icon of a calendar with the date December 17 is to the right. On the line below a white icon of a calendar that says December 4, and white text that says: Annual Drug Price Transparency hearing on December 4, 2025 at 1:30 pm. Oregonians are encouraged to share their prescription drug story before or during the hearing at: dcbspage.org/RXSTORIES
Wednesday the #Oregon #PDAB met. Highlights include:
- Leadership changes
- Annual report data
- Policy recommendations
Next meeting is Dec. 17, 2025 at 8 am.
We'll keep you posted! #HealthPolicySky #ORPol
The rise of lung cancer among non-smokers is a silent crisis. And for cities like Delhi, the numbers are alarming. A quick explainer 👇
Thread: #PublicHealth #HealthPolicySky
Great news coming out of Maryland! We're excited to see them move closer to a #PriceCap on some of the most expensive prescription drugs.
Lots of great advocacy by our friends at @mdhealthcareforall.bsky.social
marylandmatters.org/2025/11/17/m...
#Oregon #UpperPaymentLimit #PDAB #HealthPolicySky
Today is #WorldDiabetesDay! Lifesaving #antidiabetic medication (#GLP1s, #insulin, etc.) should be #affordable for everyone!
#Diabetes #HealthPolicySky #Oregon
We know that #Oregon can follow Colorado's lead. Let’s strengthen our #PDAB so it can finally put #patients (not profits) first. (2/2)
www.streetroots.org/news/2025/11...
#RXDrugPrices #HealthPolicySky
#Oregon’s #PDAB was built to lower #RXDrug prices, but power interests and the industry's murky pricing systems are keeping it from doing its job. Meanwhile, states like Colorado are proving that real #reform IS possible. (1/2)
www.streetroots.org/news/2025/11...
#HealthPolicySky
An orange background with faint white "graph paper" boxes. A black and white prescription bottle with a roll of $50 bills coming out is at the top around some clouds. Below black text says Did you know that (highlighted) drug prices outpaced inflation (end highlight) again in 2024? Smaller italicized text says Source: Oregon Prescription Drug Price Transparency Program results and recommendations – 2024
Prescription drug costs rose higher than the rate of #inflation AGAIN, with some medications up more than 15%.
#Transparency exposes these trends and helps drive solutions. Let’s make drug pricing fair and open.
#RXDrugPrices #Oregon #HealthPolicySky
Great insight into what states are doing to lower prescription costs for patients— including setting price caps or Upper Payment Limits!
stateline.org/2025/10/30/d...
#RXDrugCost #PDAB #UPL #HealthPolicySky
The #OneBigBeautifulBill (HR.1) will cost taxpayers even more than previously reported -- thanks to a "small" provision #BigPharma lobbied for.
www.fiercehealthcare.com/regulatory/e...
#HealthPolicySky #RXDrugPrices
Prescription drugs aren't #accessible if people can't afford them!
#HealthPolicySky #PrescriptionDrugs #ORPol #Oregon #PDAB
A green background with a white border. White text at the top says: New Leadership. Below text says: Michele Koder was appointed as a new board member, bringing pharmacy and Medicaid expertise. A picture of a blond woman in a blue shirt is to the right. In the next line, a picture of a woman with short dark hair and white text that says: Sarah Young joined as Executive Director—a leader in rural health policy and drug price transparency.
A green background with a white border. White text at the top says: Policy Discussion. White text below says: The board discussed legislative policy recommendations to be voted on in November.Highlights included: Pharmacy Benefit Manager (PBM) Reform Auditing the 340B Program PDAB’s role and future Exploring authority to set Upper Payment Limits (UPLs). To the right there are two white line icons, one with a legislative policy with a pill and the other shows three pills.
A green background with a white border. White text at the top says: Affordability Reviews. Below white text says: Reviewed seven insulin glargine products (an essential diabetes medication) Found data errors and outdated pricing info. Noted impact of Oregon’s $35 insulin co-pay cap that reduced costs for patients, but not overall system spending. Work to refine access and equity metrics for affordability reviews.
A green background with a white border. White text at the top says: Looking Ahead. White text below says: Next PDAB Meeting: November 19, 2025 at 8 am, PDAB will review a draft of their Legislative Report due in December. A white icon of a calendar with the date November 19 is to the right. On the line below a white icon of a calendar that says December 4, and white text that says: Annual Drug Price Transparency hearing on December 4, 2025 at 1:30 pm. Oregonians are encouraged to share their prescription drug story before or during the hearing at: dcbspage.org/RXSTORIES
Yesterday the #Oregon #PDAB met. Highlights include:
- New leadership
- Public comments
- Policy conversations
- Insulin affordability reviews
Next meeting is Nov. 19, 2025 at 8 am.
We'll keep you posted! #HealthPolicySky #ORPol
It's past time for a clear and focused effort to lower prescription drug prices! Americans are struggling!
www.axios.com/2025/10/12/t...
#ORPol #PrescriptionDrugPrices #Pharma #Tariffs #MostFavoredNation #Oregon #OCAP #HealthPolicySky
Pale yellow background, black text reads Have you or someone you know paid a high price for: a lime green box with a purple insulin pen icon and white text reads Toujeo Max Solostar or Toujeo SoloStar Generic: None Therapy Class: Insulin. Below the box black text reads Consider sharing your story with the Oregon Prescription Drug Affordability Board
Have you or someone you know paid a high price for #ToujeoMaxSolostar or #ToujeoSoloStar?
The #Oregon #PDAB is reviewing high-cost drugs that may strain Oregonians & they need to hear from YOU! Next meeting: Oct 15 @ 8 am.
Comment at: bit.ly/or-pdab-comment
#HealthPolicySky #Insulin #Diabetes
Pale yellow background, black text reads Have you or someone you know paid a high price for: a teal box with an indigo insulin vial icon and white text reads Semglee-yfgn Generic: Insulin Gargine-yfgn Therapy Class: Insulin. Below the box black text reads Consider sharing your story with the Oregon Prescription Drug Affordability Board
Have you or someone you know paid a high price for #Semglee-yfgn?
The #Oregon #PDAB is reviewing high-cost drugs that may strain Oregon patients & they need to hear from YOU! The next meeting is Oct 15 @ 8 am.
Comment at: bit.ly/or-pdab-comment
#HealthPolicySky #Insulin #Diabetes #OCAP
Pale yellow background, black text reads Have you or someone you know paid a high price for: Lantus SoloStar or Lantus a dark purple box with a lavendar insulin vial icon, lavendar insulin pen icon and white text reads Lantus SoloStar or Lantus Generic: None Therapy Class: Insulin. Below the box black text reads Consider sharing your story with the Oregon Prescription Drug Affordability Board
Have you or someone you know paid a high price for #LantusSoloStar or #Lantus?
The #Oregon #PDAB is reviewing high-cost drugs that may strain Oregon patients & they need to hear from YOU! The next meeting is Oct 15 @ 8 am.
Comment at: bit.ly/or-pdab-comment
#HealthPolicySky #Insulin #Diabetes
Pale yellow background, black text reads Have you or someone you know paid a high price for: a purple box with a teal insulin vial icon and white text reads Insulin Glargine-yfgn Generic of Semglee None Therapy Class: Insulin. Below the box black text reads Consider sharing your story with the Oregon Prescription Drug Affordability Board
Have you or someone you know paid a high price for #InsulinGlargine-yfgn?
The #Oregon #PDAB is reviewing high-cost drugs that may strain Oregon patients & they need to hear from YOU! The next meeting is Oct 15 @ 8 am.
Comment at: bit.ly/or-pdab-comment
#HealthPolicySky #Insulin #Diabetes #OCAP
Great News from #Colorado! Their Prescription Drug Affordability Board (#PDAB) set an Upper Payment Limit on the expensive prescription medication, #Enbrel!
www.koaa.com/news/local-n...
#PrescriptionDrugPrices #AffordableRX #UpperPaymentLimit #Oregon #ORPol #OCAP #HealthPolicySky
Pale yellow background, black text reads Have you or someone you know paid a high price for: a teal box with a yellow-green insulin pen icon and white text reads Basaglar KwikPen Generic: None Therapy Class: Insulin. Below the box black text reads Consider sharing your story with the Oregon Prescription Drug Affordability Board
Have you or someone you know paid a high price for #BasaglarKwikPen?
The #Oregon #PDAB is reviewing high-cost drugs that may strain Oregon patients & they need to hear from YOU! The next meeting is Oct 15 at 8 am.
Comment at: bit.ly/or-pdab-comment
#HealthPolicySky #Insulin #Diabetes #OCAP
Red background with white text that says: In 2024, nearly 160 Oregonians skipped or reduced does so a prescription would last longer. Below smaller white text says Source: Source: Oregon Health Insurance Survey Program. (2024). Cost Dashboard. Published January 2025. OCAP logo.
The system is not working for Oregonians. Join us in pushing for change!
#HealthPolicySky #Oregon #OrPol #RXDrugCosts #PrescriptionDrugAffordability #OCAP
Looking ahead: Next #Oregon #PDAB Meeting Oct. 15 @ 8am
Affordability Reviews on #insulin:
#BasaglarKwikPen
#InsulinGlardine-yfgn
#Lantus
#LantusSolorStar
#Semglee-yfgn
#ToujeoMaxSolarStar
#ToujeoSoloStar
#HealthPolicySky
Green background, white border, white text says Program Updates Sarah Young will be the new Executive Director of PDAB + Drug Price Transparency Program. Michelle Coder (Mount Loma Health) selected to join the board; first meeting Oct. 15, pending Senate confirmation. Dr. Dan Hartung, Dr. Chris Layman & Dan Kennedy reappointed through Dec. 2029. 9th Circuit upheld OR’s HB 4005 drug price transparency law, affirming state authority to collect price increase data (critical for PDAB’s work). Icon of a gavel
Green background, white border, white text says Draft Policy Ideas PDAB past wins: capped insulin at $35/month, made PBMs report more data. New Ideas: One PBM for Medicaid → lower costs and better access Change PBM payment system → more transparency Audit 340B program → more transparency OHA expert may present on the Array RX system. Discussion about how studying the entire drug delivery system might mean adding new voices to the board. Staff will compile ideas for next month. Icon of two speech bubbles
Green background, white border, white text says Affordability Reviews Jardiance: Approved in 2014, patent ends 2026 On Medicare price negotiation list starting 2026 Price has gone up ~5% each year since 2018 PDAB noted payers get big discounts (≈60%) Mounjaro: Approved in 2022, patents run into the 2030s Not on Medicare price list Price rising ~5% per year PDAB discussed patient struggles with insurance coverage leading to treatment gaps Ozempic: Approved in 2017, patents expire 2025–2028 On Medicare price list starting 2027 Price rising ~5% per year PDAB questioned a sudden 2020–21 price dip and noted pharmacies sometimes paying above list price Icon of a prescription drug bottle with two pills on the outside
Green background, white border, white text says Affordability Reviews Rybelsus: Approved in 2017, patents through 2039 On Medicare price list starting 2027 Price rising ~5% per year PDAB flagged strict use instructions (empty stomach, specific water, wait time) as a barrier for patients Trulicity: Approved in 2014, no active patents Not on Medicare price list Price has barely risen (~0.6% per year) PDAB noted Medicare patients may still pay more than others Overall, PDAB heard from staff and providers that transparency remains limited in 340B reporting, with many declining to share payment data.
On Friday the #Oregon #PDAB met. Here are the Highlights:
➡️New executive director and board member
➡️Draft policy ideas
➡️Discussions about the cost Oregonians pay for #Jardiance, #Mounjaro, #Ozempic, #Rybelsus, #Trulicity
➡️ Final comments for affordability reviews by Oct 15
#HealthPolicySky
Pale yellow background, black text reads Have you or someone you know paid a high price for: a dark purple box with a syringe with lime green liquid and white text reads Trulicity Generic: None Therapy Class: Antidiabetics. Below the box black text reads Consider sharing your story with the Oregon Prescription Drug Affordability Board
Have you or someone you know paid a high price for #Trulicity?
The #Oregon #PDAB is reviewing high-cost drugs that may strain Oregon patients & they need to hear from YOU! The next meeting is Sept 17 at 8 am. Comment at: bit.ly/or-pdab-comment #Antidiabetic #Diabetes #HealthPolicySky
Pale yellow background, black text reads Have you or someone you know paid a high price for: a dark blue box with a yellow pill bottle and white text reads Rybelsus Generic: None Therapy Class: Antidiabetics. Below the box black text reads Consider sharing your story with the Oregon Prescription Drug Affordability Board
Have you or someone you know paid a high price for #Rybelsus?
The #Oregon #PDAB is reviewing high-cost drugs that may strain Oregon patients & they need to hear from YOU! The next meeting is Sept 17 at 8 am. Comment at: bit.ly/or-pdab-comment #Antidiabetic #Diabetes #HealthPolicySky
Pale yellow background, black text reads Have you or someone you know paid a high price for: a purple box with a syringe filled with pink liquid and white text reads Mounjaro Generic: No longer available Therapy Class: Antidiabetics. Below the box black text reads Consider sharing your story with the Oregon Prescription Drug Affordability Board
Have you or someone you know paid a high price for #Mounjaro? The #Oregon #PDAB is reviewing high-cost drugs that may strain Oregon patients & they need to hear from YOU! The next meeting is Sept 17 at 8 am. Comment at: bit.ly/or-pdab-comment #Antidiabetic #Diabetes #HealthPolicySky
Pale yellow background, black text reads Have you or someone you know paid a high price for: a dark teal box with a syringe with red liquid and white text reads Ozempic Generic: None Therapy Class: Antidiabetics. Below the box black text reads Consider sharing your story with the Oregon Prescription Drug Affordability Board
Have you or someone you know paid a high price for #Ozempic?
The #Oregon #PDAB is reviewing high-cost drugs that may strain Oregon patients & they need to hear from YOU! The next meeting is Sept 17 at 8 am. Comment at: bit.ly/or-pdab-comment #Antidiabetic #Diabetes #HealthPolicySky
